Gaurav Chaudhry

Contribute & provide overall business strategy and direction, work closely with business to advise and develop scientific and medical strategies in focus products.
Provide medical and scientific training to field force and ensure timely response to medical information requests. Attend and/or speak at scientific meetings/ conferences/ symposia and disseminate scientific information health care providers. Identify, develop and nurture relationships with HCPs that are centered on science and with highest ethical and professional standards and presenting relevant scientific information to external stakeholders including health care professionals.
Support registration of new products and life cycle management.

Medical resource to the company as a whole and particularly in clinical research (protocol and CRF writing, adverse events, discussions with investigators, internal meetings). Support marketing in gathering scientific information and developing fair and balanced marketing tools, Training to associates and sales representatives, KOL Management, planning and conducting Advisory boards, represent the company to groups of experts, societies, regulatory bodies and at international meetings.

Member of COVID-19 task force, Expert committee consensus development for use of adsorptive therapies in COVID-19, Digital transformation of medical activities , Helped in creation of SOPs for creation of ‘PD Ready Centers’ and ‘CoE for Acute therapies’, Supported Digital Simulation workshops for Volatile Anesthetics, Supported launch of newer therapies in various therapeutic areas (PD4 solution, Theranova, Starling hymodynamic monitor, Claria Homechoice APD), Team Management

Launch of new products in Acute therapies (RCA & MARS), Establish local protocols for the use of dilute regional citrate anticoagulation (RCA) with CRRT, Standardization of CRRT practice, Supported regional team in training internal (field force) and external (HCPs), Speaker at various national and international forums on CRRT, adsorptive therapies and RCA

Global launch of Tenecteplase (TNK-tPA) in stroke management • Indian Registry in Ischemic Stroke with Tenecteplase (IRIS-TNK): Study design, Protocol, CRF & consent form design, identification of investigators, support document submission for IRB reviews

Life cycle management of spectrum (Acute care: Alteplase in management of AIS, PE and AMI, Tenecteplase in AMI, Dabigatran etexilate in SPAF, pVTEp; aVTE) products. • Developing consensus on the use of dabigatran in pVTEp • Support team in developing stroke centers • Team management

Launch of dabigatran in aVTE and Idarucizumab • Indian Consensus guidance on SPAF with focus on NOACs • Speaker at various National conferences e.g., Cardiological Society of India • Life cycle management of spectrum products

Launch of dabigatran in pVTEp • Life cycle management of spectrum products

Launch of dabigatran in SPAF • Support in smooth functioning SPAF Academy • Support consensus development on the use of Tenecteplase in AMI • Travelled to South Africa to help train local team on medical aspects of dabigatran and establish local MA function

Handling calls from the patients - Health Evaluation of patients over the phone, prescribing Medications, Tests, Referral protocols • Preparing Protocols (For reference of other Doctors). • Preparing OTC Drug List considering safety of patients and Medico-Legal aspect

Handling emergencies alone and with team – Evaluation and Management of the patients. • Visiting corporate clients – Evaluation and minor general medical care. • Handling IPD. • Handling minor surgical emergencies.